IL6 and metabolic dysfunction-associated steatotic liver disease: Systemic inflammatory markers such as interleukin-6 (IL-6) and tumor necrosis factor alpha have been found to be elevated in the serum of patients with MASLD and are considered responsible for cardiovascular effects.13